Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 24Active not recruiting 13Not yet recruiting 4Completed 3Enrolling by invitation 2Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 10Glioblastoma 10Breast Neoplasms 10Neoplasms 9Carcinoma, Non-Small-Cell Lung 8Neoplasm Metastasis 7Lung Neoplasms 6Colorectal Neoplasms 6Carcinoma, Hepatocellular 6Prostatic Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Pancreatic Neoplasms 5Hematologic Neoplasms 5Ovarian Neoplasms 4Myelodysplastic Syndromes 4Multiple Myeloma 4Glioma 4Carcinoma, Renal Cell 4Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma 3Melanoma 3Head and Neck Neoplasms 3Astrocytoma 3Urinary Bladder Neoplasms 2Solid Tumors 2Solid Tumor 2Recurrence 2Rectal Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2

Interventions

Surgical Procedures, Operative 1Oxaliplatin 1Leucovorin 1Irinotecan 1Fluorouracil 1Congresses as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Adenocarcinoma Of Esophagus × 90 days × Clear all
NCT02366819 2026-03-30

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

University of Chicago

Phase 4 Suspended
36 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡